Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
The complexity and cost of vaccine manufacturing – An overviewVaccine, 2017-07, Vol.35 (33), p.4064-4071 [Peer Reviewed Journal]The Authors ;2017 The Authors ;Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved. ;Copyright Elsevier Limited Jul 24, 2017 ;2017 The Authors 2017 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2017.06.003 ;PMID: 28647170Full text available |
|
2 |
Material Type: Article
|
An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemicVaccine, 2021-01, Vol.39 (3), p.495-504 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2020.12.022 ;PMID: 33342632Full text available |
|
3 |
Material Type: Article
|
Optimal planning of the COVID-19 vaccine supply chainVaccine, 2021-08, Vol.39 (37), p.5302-5312 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2021.07.068 ;PMID: 34373118Full text available |
|
4 |
Material Type: Article
|
India’s cost-effective COVID-19 vaccine development initiativesVaccine, 2020-11, Vol.38 (50), p.7883-7884 [Peer Reviewed Journal]2020 Elsevier Ltd ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2020.10.056 ;PMID: 33129610Full text available |
|
5 |
Material Type: Article
|
Status of research and development of vaccines for Streptococcus pyogenesVaccine, 2016-06, Vol.34 (26), p.2953-2958 [Peer Reviewed Journal]The Authors ;2016 World Health Organization ;Copyright © 2016 World Health Organization. Published by Elsevier Ltd.. All rights reserved. ;Copyright Elsevier Limited Jun 3, 2016 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2016.03.073 ;PMID: 27032515Full text available |
|
6 |
Material Type: Article
|
Current and future cholera vaccinesVaccine, 2020-02, Vol.38, p.A118-A126 [Peer Reviewed Journal]2019 The Author(s) ;Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved. ;2019. The Author(s) ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2019.12.011 ;PMID: 31879125Full text available |
|
7 |
Material Type: Article
|
A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infantsVaccine, 2017-10, Vol.35 (45), p.6228-6237 [Peer Reviewed Journal]2017 The Authors ;Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved. ;Copyright Elsevier Limited Oct 27, 2017 ;2017 The Authors 2017 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2017.09.014 ;PMID: 28967523Full text available |
|
8 |
Material Type: Article
|
COVID-19 vaccine hesitancy: Lessons from IsraelVaccine, 2021-06, Vol.39 (29), p.3785-3786 [Peer Reviewed Journal]2021 Elsevier Ltd ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2021.05.085 ;PMID: 34090701Full text available |
|
9 |
Material Type: Article
|
Emerging manufacturers engagements in the COVID −19 vaccine research, development and supplyVaccine, 2020-07, Vol.38 (34), p.5418-5423 [Peer Reviewed Journal]2020 The Author(s) ;Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved. ;2020. The Author(s) ;2020 The Author(s) 2020 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2020.06.022 ;PMID: 32600908Full text available |
|
10 |
Material Type: Article
|
Resource allocation for different types of vaccines against COVID-19: Tradeoffs and synergies between efficacy and reachVaccine, 2021-11, Vol.39 (47), p.6876-6882 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2021.10.025 ;PMID: 34688498Full text available |
|
11 |
Material Type: Article
|
Poor association between 13-valent pneumococcal conjugate vaccine-induced serum and mucosal antibody responses with experimental Streptococcus pneumoniae serotype 6B colonisationVaccine, 2024-04, Vol.42 (12), p.2975-2982 [Peer Reviewed Journal]2024 The Author(s) ;Copyright © 2024 The Author(s). Published by Elsevier India Pvt Ltd. All rights reserved. ;2024. The Author(s) ;2024 The Author(s) 2024 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2024.03.055 ;PMID: 38570270Digital Resources/Online E-Resources |
|
12 |
Material Type: Article
|
Influence of the intestinal microbiota on the immunogenicity of oral rotavirus vaccine given to infants in south IndiaVaccine, 2018-01, Vol.36 (2), p.264-272 [Peer Reviewed Journal]2017 The Author(s) ;Copyright © 2017 The Author(s). Published by Elsevier Ltd.. All rights reserved. ;2017. The Author(s) ;2017 The Author(s) 2017 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2017.11.031 ;PMID: 29217369Full text available |
|
13 |
Material Type: Article
|
Pertussis vaccination during pregnancy in Vietnam: Results of a randomized controlled trial Pertussis vaccination during pregnancyVaccine, 2016-01, Vol.34 (1), p.151-159 [Peer Reviewed Journal]Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 2, 2016 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2015.10.098 ;PMID: 26529073Full text available |
|
14 |
Material Type: Article
|
Do vaccines increase or decrease susceptibility to diseases other than those they protect against?Vaccine, 2024-01, Vol.42 (3), p.426-440 [Peer Reviewed Journal]2023 Elsevier Ltd ;Copyright © 2023 Elsevier Ltd. All rights reserved. ;2023. Elsevier Ltd ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2023.12.060 ;PMID: 38158298Full text available |
|
15 |
Material Type: Article
|
Covid-19 vaccine trials: Ethnic diversity and immunogenicityVaccine, 2021-06, Vol.39 (27), p.3541-3543 [Peer Reviewed Journal]2021 Elsevier Ltd ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2021.05.017 ;PMID: 34049734Full text available |
|
16 |
Material Type: Article
|
Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22–23 March 2017Vaccine, 2018-02, Vol.36 (7), p.921-931 [Peer Reviewed Journal]2017 The Authors ;Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved. ;2017. The Authors ;2017 The Authors 2017 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2017.12.029 ;PMID: 29336923Full text available |
|
17 |
Material Type: Article
|
The origins of the vaccine cold chain and a glimpse of the futureVaccine, 2017-04, Vol.35 (17), p.2115-2120 [Peer Reviewed Journal]2017 ;Copyright © 2017. Published by Elsevier Ltd. ;Copyright Elsevier Limited Apr 19, 2017 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2016.11.097 ;PMID: 28364918Full text available |
|
18 |
Material Type: Article
|
Marketing the COVID-19 vaccine and the implications for public healthVaccine, 2021-08, Vol.39 (34), p.4766-4768 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2021.07.015 ;PMID: 34281742Full text available |
|
19 |
Material Type: Article
|
Dynamics of G2P[4] strain evolution and rotavirus vaccination: A review of evidence for RotarixVaccine, 2020-07, Vol.38 (35), p.5591-5600 [Peer Reviewed Journal]2020 GlaxoSmithKline Biologicals S.A. ;Copyright © 2020 GlaxoSmithKline Biologicals S.A. Published by Elsevier Ltd.. All rights reserved. ;2020. GlaxoSmithKline Biologicals S.A. ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2020.06.059 ;PMID: 32651115Full text available |
|
20 |
Material Type: Article
|
Public opinion on global COVID-19 vaccine procurement and distribution policies: A nationally representative survey in Aotearoa New Zealand 2022Vaccine, 2024-02, Vol.42 (6), p.1372-1382 [Peer Reviewed Journal]2024 The Author(s) ;Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved. ;2024. The Author(s) ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2024.01.091 ;PMID: 38326132Full text available |